Clinical Trial Update: Biomarkers and Early Alzheimer's Disease

View source ↗

Summary

The National Institute on Aging reports a clinical trial investigating biomarkers in early Alzheimer's disease; the current status of the trial is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer's Disease | Status: UNKNOWN